Medical News

MedPage Today Product Alert

Physicians...get the latest breaking news on Product Alerts. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.

Another Day, Another ARB, Another Contaminant

Losartan lots from Indian drugmaker recalled for novel carcinogen

FDA: Clot Risk Up for Xeljanz in RA

Safety signal detected for higher dose of JAK inhibitor in postmarketing trial

FDA: Gout Drug Raises Death Risk

Black box warning, second-line use being required

FDA Approves Next-Gen TAVR Device

Sapien 3 Ultra approved for intermediate and greater risk patients

FDA: Immune Tx Monotherapy in Bladder Ca May Worsen Survival

Pembrolizumab, atezolizumab trials stop enrolling patients with low PD-L1

FDA: Stopping Fingolimod May Exacerbate MS

Rare effects including severely increased disability, multiple new lesions

Warfarin INR Test Strips Recalled

Class I recall for over 1.1 million packages of test strips

FDA: Irbesartan Under Recall Too in the Midst of Valsartan Saga

Another ARB found to contain a potential carcinogen in some lots

Morning Break: Male Menopause; Oops, Wrong Kidney; Fertility Apps' Accuracy

Health news and commentary from around the Web gathered by the ALLMedPage Today staff

Valsartan Recall Expanded, FDA Investigating Products from Outside China

Other ARB manufacturers subject to FDA investigation